Literature DB >> 19736391

Cost implication of irrational prescribing of chloroquine in Lagos State general hospitals.

Bolajoko A Aina1, Fola Tayo, Ogori Taylor.   

Abstract

BACKGROUND: A major share of the hospital budget is spent on drugs. Irrational use of these drugs is a waste of financial and human resources that could have been deployed for another use within the hospital setting especially in cases where such drugs are provided free to patients. Also there is increased morbidity and progression of severity with irrational use. The objective of this study was to determine the irrational use of chloroquine and the subsequent cost implications in Lagos State general hospitals.
METHODOLOGY: A retrospective study period of one year (January to December, 2000) was selected. A total of 18,781 prescription forms of "Free Eko Malaria" were sampled for children and adults from all the Lagos State general hospitals. Drug costs in each prescription form were identified. Cost effectiveness analysis of chloroquine tablet and intramuscular injection was undertaken.
RESULTS: The average cost of medicine per prescription was 132.071 ($1.03) which should have been 94.22 ($0.73) if prescribed rationally. The total cost of prescriptions for malaria under study was 2,480,425.00 ($19,348.09). About 68% {(1,679,444.00) ($13,100.19)} of the total cost was lost to irrational prescribing. This is a waste of scarce resources. When the prescriptions were differentiated into the different dosage forms prescribed, the prescriptions containing intramuscular injections only had over 90% of the cost lost to irrational prescribing. Cost effectiveness analysis showed that chloroquine tablet was 17 times more cost effective than chloroquine injection (intramuscular) from a health care system perspective while it was 14 times more cost effective from a patient perspective.
CONCLUSION: There is waste of scarce resources with irrational dispensing of drugs and these resources could have been deployed to other uses or areas within the hospitals. The tablet chloroquine was more cost effective than injection chloroquine (intramuscular). Increasing the cost of tablets, decreasing effectiveness of tablets, decreasing the cost of injections and increasing the effectiveness of injections did not change the cost effectiveness conclusion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19736391     DOI: 10.3855/jidc.325

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  6 in total

1.  Rapid evolution of fluoroquinolone-resistant Escherichia coli in Nigeria is temporally associated with fluoroquinolone use.

Authors:  Adebayo Lamikanra; Jennifer L Crowe; Rebeccah S Lijek; Babatunde W Odetoyin; John Wain; A Oladipo Aboderin; Iruka N Okeke
Journal:  BMC Infect Dis       Date:  2011-11-07       Impact factor: 3.090

2.  The economic impact of substandard and falsified antimalarial medications in Nigeria.

Authors:  Sarah M Beargie; Colleen R Higgins; Daniel R Evans; Sarah K Laing; Daniel Erim; Sachiko Ozawa
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

3.  Amitriptyline prescribing in public sector healthcare facilities in the Western Cape, South Africa.

Authors:  Renier Coetzee; Yasmina Johnson; Johan van Niekerk; Mosedi Namane
Journal:  PLoS One       Date:  2020-04-20       Impact factor: 3.240

4.  Retrospective assessment of acute poisoning incidents by pharmaceutical agents in Jordan: Data from Pharmacy One™ Poison Call Center, 2014 to 2018-Part II.

Authors:  Alaa Yehya; Dima Albals; Reem Issa; Aida Fawadleh
Journal:  Pharmacol Res Perspect       Date:  2020-04

5.  Patent medicine dealers and irrational use of medicines in children: the economic cost and implications for reducing childhood mortality in southeast Nigeria.

Authors:  Benjamin S C Uzochukwu; Obinna E Onwujekwe; Chinenye Okwuosa; Ogochukwu P Ibe
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

6.  Irrational Use of Medicines-A Summary of Key Concepts.

Authors:  Richard Ofori-Asenso; Akosua Adom Agyeman
Journal:  Pharmacy (Basel)       Date:  2016-10-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.